Tissue Selective Estrogen Complex to Prevent Metabolic Dysfunction in Women (TSEC)
Phase of Trial: Phase 0
Latest Information Update: 13 Jun 2017
At a glance
- Drugs Conjugated estrogens/bazedoxifene (Primary)
- Indications Menopause; Postmenopausal osteoporosis
- Focus Therapeutic Use
- Acronyms RISE
- Sponsors Pennington Biomedical Research Center
- 13 Jun 2017 Results presented at the 77th Annual Scientific Sessions of the American Diabetes Association
- 26 Sep 2016 Planned End Date changed from 1 Jan 2017 to 1 Jun 2017.
- 26 Sep 2016 Planned primary completion date changed from 1 Oct 2016 to 1 Jun 2017.